Regions Financial Corp’s Dr. Reddy's Laboratories RDY Stock Holding History

Regions Financial Corp’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,225	Closed	-$8K	–	2076
2018 Q2	$8K	Hold	1,225	–	–	﹤0.01%	1704
2018 Q1	$8K	Sell	1,225 -500	-29%	-$3.5K	﹤0.01%	1685
2017 Q4	$13K	Buy	+1,725	New	+$12.4K	﹤0.01%	1626
2017 Q1	–	Sell	-93,985	Closed	-$851K	–	901
2016 Q4	$851K	Sell	93,985 -2,055	-2%	-$19.1K	0.01%	551
2016 Q3	$892K	Buy	+96,040	New	+$917K	0.01%	525
2014 Q2	–	Sell	-116,755	Closed	-$1.02M	–	1130
2014 Q1	$1.02M	Buy	116,755 +15,110	+15%	+$131K	0.01%	569
2013 Q4	$835K	Buy	101,645 +24,900	+32%	+$197K	0.01%	626
2013 Q3	$580K	Buy	76,745 +15,740	+26%	+$114K	0.01%	701
2013 Q2	$461K	Buy	+61,005	New	+$445K	0.01%	741

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Regions Financial Corp's RDY Position: Q3 2018 in Review

Regions Financial Corp sold out of Dr. Reddy's Laboratories (RDY) in Q3 2018, closing a stake of 1,225 shares — an estimated $8K sold.

Regions Financial Corp first reported a position in RDY in Q2 2013 and held it in 9 quarters. The position peaked at $1.02M in Q1 2014. 125 funds tracked by Wall St. Rank hold RDY as of Q3 2018.

Regions Financial Corp reported no remaining Dr. Reddy's Laboratories position as of Q3 2018 after selling out during the quarter.
Regions Financial Corp sold 1,225 Dr. Reddy's Laboratories shares in Q3 2018, an estimated $8K.
Regions Financial Corp first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 9 quarters.
Regions Financial Corp's Dr. Reddy's Laboratories position peaked at $1.02M in Q1 2014.
125 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2018.

Based on Regions Financial Corp's 13F filing for Q3 2018, filed 22 Oct 2018.